WRN promoter CpG island hypermethylation does not predict more favorable outcomes for patients with metastatic colorectal cancer treated with irinotecan-based therapy
L. Bosch, Y. Luo, V. Lao, P. Snaebjornsson, G. Trooskens, I. Vlassenbroeck, S. Mongera, W. Tang, P. Welcsh, J. Herman, M. Koopman, I. Nagtegaal, C. Punt, W. Van Criekinge, G. Meijer, R. Monnat,, B. Carvalho and W. Grady
(2016) CLINICAL CANCER RESEARCH,
22,